Envoy Medical, Inc. (COCH)

NASDAQ: COCH · IEX Real-Time Price · USD
5.05
-1.03 (-16.94%)
Apr 12, 2024, 4:00 PM EDT - Market closed
-16.94%
Market Cap 98.98M
Revenue (ttm) 316,000
Net Income (ttm) -29.91M
Shares Out 19.60M
EPS (ttm) -2.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 164,004
Open 6.08
Previous Close 6.08
Day's Range 4.70 - 6.23
52-Week Range 0.75 - 11.72
Beta 1.24
Analysts Strong Buy
Price Target 6.00 (+18.81%)
Earnings Date May 16, 2024

About COCH

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1995
Employees 34
Stock Exchange NASDAQ
Ticker Symbol COCH
Full Company Profile

Financial Performance

In 2023, Envoy Medical's revenue was $316,000, an increase of 33.33% compared to the previous year's $237,000. Losses were -$29.91 million, 87.8% more than in 2022.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for COCH stock is "Strong Buy." The 12-month stock price forecast is $6.0, which is an increase of 18.81% from the latest price.

Price Target
$6.0
(18.81% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , April 3, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (...

10 days ago - PRNewsWire

Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems...

10 days ago - GlobeNewsWire

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Company Provides Corporate Update that Include Updates on its Investigational Fully Implanted Acclaim® Cochlear Implant Meeting its Early Feasibility Study Milestones

11 days ago - GlobeNewsWire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , March 24, 2024 /PRNewswire/ -- WHY:  on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business inf...

20 days ago - PRNewsWire

COCH INVESTOR ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , March 17, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. ...

27 days ago - PRNewsWire

Envoy Medical to Participate in the 36th Annual ROTH Conference

WHITE BEAR LAKE, Minnesota, March 12, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems,...

4 weeks ago - GlobeNewsWire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , March 9, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (...

5 weeks ago - PRNewsWire

Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial

Billionaire Entrepreneur Glen Taylor Commits to a 5-Year Facility to Support Company's upcoming FDA Clinical Trial for the Acclaim® Fully Implanted Cochlear Implant

5 weeks ago - GlobeNewsWire

COCH LOSS ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , March 2, 2024 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. ...

6 weeks ago - PRNewsWire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , Feb. 23, 2024 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. ...

7 weeks ago - PRNewsWire

Newly Introduced Bipartisan Bill Seeks to Clarify Fully Implanted Active Middle Ear Hearing Devices as Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage

Envoy Medical's FDA Approved Esteem® Fully Implanted Active Middle Ear Hearing Device May Now Have an Opportunity to be a Coverable Benefit

2 months ago - GlobeNewsWire

Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley

WHITE BEAR LAKE, Minnesota , Feb. 05, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing system...

2 months ago - GlobeNewsWire

Envoy Medical, Inc. to Present at The Microcap Conference

White Bear Lake, Minnesota--(Newsfile Corp. - January 30, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing syste...

2 months ago - Newsfile Corp

MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger (NASDAQ: COCH)

WASHINGTON , Jan. 22, 2024 /PRNewswire/ -- MCRA, LLC, a leading medical device and biologics focused clinical research organization (CRO) and advisory firm integrating seven core services [U.S. and In...

2 months ago - PRNewsWire

Envoy Medical Announces Three Additional Patents for Implantable Cochlear Systems

Expanding Innovation Portfolio to Support Delivering Hearing to Patients in Innovative Ways WHITE BEAR LAKE, Minnesota, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ...

2 months ago - GlobeNewsWire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Envoy Medical, Inc.- COCH

NEW YORK , Jan. 14, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Envoy Medical, Inc. ("Envoy" or the "Company") (NASDAQ: COCH). Such investors are advised to co...

3 months ago - PRNewsWire

COCH LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , Dec. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Envoy Medical, I...

3 months ago - PRNewsWire

ENVOY ALERT: Bragar Eagel & Squire, P.C. is Investigating Envoy Medical, Inc. on Behalf of Envoy Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Envoy Medical, Inc. (“Envoy” or the “Company...

4 months ago - Business Wire

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: C...

4 months ago - Business Wire

Envoy Medical to Host Fireside Chat Event December 7

Analyst Hosted Event to Feature Comprehensive Discussion of Envoy Medical's Products, Interviews with Two Study Investigators and Key Opinion Leaders in Cochlear Implants

4 months ago - GlobeNewsWire

Envoy Medical Provides Third Quarter 2023 Financial Results and Business Update

Interim Findings from Early Feasibility Trial Provide Important Learnings and Feedback Ahead of Pivotal Clinical Trial Planned for 2024

5 months ago - GlobeNewsWire

Envoy Medical Announces Publication of Additional Patent for Implantable Cochlear Systems

Newly Published Patent Contemplates an Evolving Product Portfolio to Serve the Under-Penetrated Hearing Implant Market WHITE BEAR LAKE, Minnesota, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc...

5 months ago - GlobeNewsWire

New Clinical Publication Reports First Three Patients in Early Feasibility Trial for Envoy Medical's Fully Implanted Cochlear Device

Surgical Experience with Three Initial Acclaim® Patients Documents Innovation Efforts in the Growing Cochlear Implant Market

6 months ago - GlobeNewsWire

Envoy Medical Announces Settlement Contract

WHITE BEAR LAKE, Minn., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (NASDAQ: COCH), a hearing health company, today announced the settlement of an outstanding lawsuit filed by certain forme...

6 months ago - GlobeNewsWire

Envoy Medical Announces Participation in the LD Micro Main Event XVI

Presentation on Wednesday, October 4th at 1:00 PM PT White Bear Lake, Minnesota--(Newsfile Corp. - October 3, 2023) - Envoy Medical Inc. (NASDAQ: COCH), a hearing health company, announced today that ...

6 months ago - Newsfile Corp